Epilepsy Treatment Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Wearable Devices, Conventional Devices, Implantable Devices); By Technology; By End-Use; By Region; Segment Forecast, 2023-2032

Epilepsy Treatment Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Wearable Devices, Conventional Devices, Implantable Devices); By Technology; By End-Use; By Region; Segment Forecast, 2023-2032

The global epilepsy treatment devices market size is expected treach USD 788.71 million by 2032, according ta new study by Polaris Market Research. The report “Epilepsy Treatment Devices Market Share, Size, Trends, Industry Analysis Report, By Product Type (Wearable Devices, Conventional Devices, Implantable Devices); By Technology; By End-User; By Region; Segment Forecast, 2023-2032” gives a detailed insight intcurrent market dynamics and provides analysis on future market growth.

An increased risk of endemic diseases like neurocysticercosis and malaria is tblame for the rising number of epilepsy cases. In addition, the variations in medical infrastructure, birth-related injuries, the increasing number of traffic accidents, and the availability of accessible care and health education programs are the primary drivers of the studied market. As the World Health Organization estimates, around 50 Mn people across the globe are whhave epilepsy, making it one of the most common diseases. About 4 t10 people in every 1,000 people are thought tbe affected by this condition at any given time.

In the United States, the annual rate of status epilepticus in patients of all ages ranged from 18.3 t41 per 100,000 people in November 2020. Because of the high prevalence of epilepsy, there has been an increase in the need for epilepsy monitoring equipment tensure that patients receive the appropriate treatment.

For instance, the USFDA granted BiSerenity’s electroencephalography wearable device system 510(k) clearance in January 2021. IceCap EEG wearable device and BiSerenity’s NeuronauteEEG system, both included in this clearance, are intended tenable physicians teasily monitor & evaluate the activity of epileptic patients’ brains.

Spanish startup mjn-NEURO introduced the mjn-SERAS in May 2022, which aids in seizure detection in the UK. It is a ground-breaking device that uses artificial intelligence tanticipate seizures up tthree minutes in advance. Epitel, a manufacturer of a wearable electroencephalogram system, raised USD 12.5 Mn in funding for seizure detection in February 2022.

The BRAIN initiative, launched in the United States in April 2013 tencourage research and development (R&D) related tthe functioning of the brain, is one of several government initiatives focused on developing novel and innovative devices. The Advanced Research Projects Activity (IARPA) joined the BRAIN initiative tdevelop non-invasive neural intervention devices timprove reasoning and problem-solving abilities.

Epilepsy Treatment Devices Market Report Highlights

Conveni over the forecast period is due tthe advantages of these devices, such as their portability, outstanding wireless readability, improved sensitivity rates in detecting seizures, improved mobility and quality of life for epileptic patients.

Deep brain stimulation segment dominated the market in 2022 due tincrease in the use of deep brain stimulators in the treatment of various neuromuscular conditions like dystonia, epilepsy, and Parkinson's disease.

Hospital segment held the largest revenue share, due tthe availability of trained medical staff in hospitals.

In 2022, Europe dominated the global market, due tthe large geriatric population and rising healthcare costs.

The global players include Cerbomed, ElectroCore, Cyberonics, NeuroPace, Boston Scientific, Medtronic, Medpage, Cadwell Industries, General Electric, and Philips.

Polaris Market Research has segmented the epilepsy treatment devices market report based on product type, technology, end-user, and region:

Epilepsy Treatment Devices, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

Wearable Devices

Conventional Devices

Implantable Devices

Epilepsy Treatment Devices, Technology Outlook (Revenue - USD Million, 2019 - 2032)

Vagus Nerve Stimulator

Responsive Neurostimulation

Deep Brain Stimulation

Accelerometry

Epilepsy Treatment Devices, End-User Outlook (Revenue - USD Million, 2019 - 2032)

Hospitals

Ambulatory Surgical Centers

Neurology Centers

Epilepsy Treatment Devices, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa